AnalystsRobin GarnerRobin Garner's Stock Forecasts
AnalystsRobin Garner
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4160 out of 4871 analysts
Average Return
-34.19%
Win Rate
17%1 out of 6
Risk vs Reward
Poor
Good
Robin Garner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Xeris Biopharma Holdings IncXERS | +26.87% | $2.27 | $2.88 | 2023-08-27 - 2024-08-27 | Buy |
Robin Garner Analyst Color
Get additional color on Robin Garner's coverage of popular stocks
Robin Garner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xeris Biopharma Holdings IncXERS | 2 | Buy | $4.50 | N/A | Initiates Coverage On | 2 years ago |
Cue Biopharma IncCUE | 1 | Buy | $26.00 | N/A | Maintains | 3 years ago |
Landos Biopharma IncLABP | 1 | Buy | $450.00 | N/A | Initiates Coverage On | 4 years ago |
Trillium Therapeutics IncTRIL | 1 | Hold | $18.50 | N/A | Downgrades | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Buy | $58.00 | N/A | Initiates Coverage On | 4 years ago |
Fennec Pharmaceuticals IncFENC | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.